Search Results - Crystal G. Connor
- Showing 1 - 6 results of 6
-
1
-
2
-
3
Pediatric Diabetes Consortium Type 1 Diabetes New Onset (NeOn) Study: factors associated with HbA1c levels one year after diagnosis by María J. Redondo, Crystal G. Connor, Katrina J. Ruedy, Roy W. Beck, Craig Kollman, Jamie Wood, Bruce A. Buckingham, Georgeanna J. Klingensmith, Janet Silverstein, William V. Tamborlane
Published 2013Artigo -
4
Presentation of youth with type 2 diabetes in the Pediatric Diabetes Consortium by Georgeanna J. Klingensmith, Crystal G. Connor, Katrina J. Ruedy, Roy W. Beck, Craig Kollman, Heidi Haro, Jamie Wood, Joyce M. Lee, Steven M. Willi, Eda Cengiz, William V. Tamborlane
Published 2015Artigo -
5
Race, Socioeconomic Status, and Treatment Center Are Associated with Insulin Pump Therapy in Youth in the First Year Following Diagnosis of Type 1 Diabetes by Maria H. Lin, Crystal G. Connor, Katrina J. Ruedy, Roy W. Beck, Craig Kollman, Bruce A. Buckingham, María J. Redondo, Desmond Schatz, Heidi Haro, Joyce M. Lee, William V. Tamborlane, for the Pediatric Diabetes Co Jamie R. Wood
Published 2013Artigo -
6
Association of Baseline Visual Acuity and Retinal Thickness With 1-Year Efficacy of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema by John A. Wells, Adam R. Glassman, Lee M. Jampol, Lloyd Paul Aiello, Andrew N. Antoszyk, Carl W. Baker, Neil M. Bressler, David J. Browning, Crystal G. Connor, Michael J. Elman, Frederick L. Ferris, Scott M. Friedman, Michele Melia, Dante J. Pieramici, Jennifer K. Sun, Roy W. Beck
Published 2015Artigo
Search Tools:
Related Subjects
Diabetes mellitus
Endocrinology
Medicine
Internal medicine
Pediatrics
Type 1 diabetes
Environmental health
Population
Type 2 diabetes
Body mass index
Diabetic ketoacidosis
Glycemic
Insulin
Socioeconomic status
Aflibercept
Bevacizumab
Calorie
Chemotherapy
Cohort
Demography
Diabetic macular edema
Diabetic retinopathy
Epistemology
Fallacy
Family history
Gerontology
Insulin pump
Intensive care medicine
Interquartile range
Macular edema